New 5-(pyridin-3-yl)-1,3,4-oxadiazoles derivatives as VEGFR2 inhibitors: <i>in silico</i> study, synthesis, and cytotoxicity evaluation. [PDF]
Abdulhussein AN, Oleiwi MA.
europepmc +1 more source
1, 3, 4-Oxadiazole: A Versatile Therapeutic Heterocycle
openaire +1 more source
Ataluren for the treatment of people living with nonsense mutation Duchenne muscular dystrophy: a plain language summary of Study 041. [PDF]
Wu S +3 more
europepmc +1 more source
Conversion of N<sub>2</sub> into oxadiazoles promoted by a multinuclear samarium complex. [PDF]
Shi X, Yuan Q, Chen Y, Xi Z, Wei J.
europepmc +1 more source
Editorial: Advancing treatments for protozoan diseases: from resistance mechanisms to novel therapies. [PDF]
Touz MC, Arranz-Solís D, Nardelli S.
europepmc +1 more source
Syntheses of Poly(2-hydrazino)-1, 3, 4-oxadiazoles
openaire +2 more sources
Synthesis and antimicrobial evaluation of hybrids methoxynaphthalene-<i>N</i>-acylhydrazones/1,3,4-oxadiazoles. [PDF]
Frederico Rozada AM +9 more
europepmc +1 more source
Design, synthesis and antiproliferative, apoptotic, and immunomodulatory properties of new heteroaryl pyridine-linked 1,2,4-oxadiazoles as prospective dual EGFR/BRAF<sup>V600E</sup> inhibitors. [PDF]
Gomaa HAM +9 more
europepmc +1 more source
1,3,4-oxadiazoles, heterocycles bearing one oxygen and two nitrogen atoms in a five membered ring have their application in the diverse areas of medicine.[1] This interesting group of compounds has diverse biological activities such as antibacterial, antifungal, antiviral, anticonvulsant, anticancer, anti-inflammatory, anti HIV, anti-tubercular ...
openaire +1 more source
Tri-1,3,4-Oxadiazoles Modified with Nitroimine: Balancing Energy, Sensitivity, and Thermal Stability. [PDF]
Chen F, Yu Q, Li L, Peng K, Zhu C, Yi W.
europepmc +1 more source

